BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 1, 2011
View Archived Issues
GABA-AT inhibitor shows promise to treat epilepsy and drug addiction
Read More
Tianjin Institute of Pharmaceutical Research discloses new agents for diabetes
Read More
Johnson & Johnson presents potential novel approach to treat diabetes and obesity
Read More
New gamma-secretase modulator shows promise in Alzheimer's disease models
Read More
Promising phase II data on NH-004 trigger additional grant from MJFF to NeuroHealing Pharmaceuticals
Read More
Apremilast completes phase II study in vulvar pain
Read More
New cannabinoid CB2 receptor agonists described
Read More
Bristol-Myers Squibb presents new chemokine CCR2 receptor modulators
Read More
Biotica claims novel sanglifehrin analogues for viral infections
Read More
British company patents novel neuropeptide Y2 receptor ligands
Read More
New monoamine reuptake inhibitors synthesized at NeuroSearch
Read More
Cleveland-based researchers to jointly launch phase I stem cell trial for MS
Read More
KemPharm and MonoSol Rx to codevelop KP-415 for ADHD
Read More
Enrollment complete in three phase III studies of TMC-435
Read More
Kuros Biosurgery completes enrollment in diabetic foot ulcer study
Read More
MorphoSys initiates dosing in MOR-202 multiple myeloma trial
Read More
DSMB recommends continuation of pivotal X-PECT study of perifosine
Read More
Tarceva approved in E.U. for specific subtype of non-small cell lung cancer
Read More
Anacor and MMV extend development agreement for malaria drug
Read More
Mitsubishi Tanabe files for approval of tenegliptin in Japan
Read More
Titan Pharmaceuticals schedules pre-NDA meeting for Probuphine
Read More
Bristol-Myers and Health Canada issue new safety information regarding Sprycel
Read More
Kissei obtains Japanese rights to DNA topoisomerase 2 inhibitor for anthracycline extravasation
Read More
Data presented from metastatic colorectal cohort of phase II trial of Delcath chemosaturation system
Read More
New approval for Cipher Pharmaceuticals' CIP-Tramadol ER
Read More